Metraipolis › archive › dc_9bc6a95eee1e

Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report — Europe PMC PMID:42405271

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42405271
DOI
10.1002/jha2.70342
License (as archived)
solo-consultazione
Archived
2026-10-08T14:29:52.470Z
SHA-256 of the archived text
03f9ceeca5ac454d9d3d13ae0d8b9a36574246edd066743a2a7337b26f0f1220
Stable URL of this page
https://metraipolis.com/documento/dc_9bc6a95eee1e

How to cite

Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report — Europe PMC PMID:42405271 — Europe PMC (en), https://europepmc.org/article/MED/42405271 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9bc6a95eee1e (Metraipolis archive dc_9bc6a95eee1e, sha256 03f9ceeca5ac454d9d3d13ae0d8b9a36574246edd066743a2a7337b26f0f1220)
BibTeX
@misc{dc9bc6a95eee1e,
  title = {Targeting CD162 for Life-Threatening Cutaneous Chronic Graft-Versus-Host Disease: A Case Report — Europe PMC PMID:42405271},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42405271},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9bc6a95eee1e; sha256 03f9ceeca5ac454d9d3d13ae0d8b9a36574246edd066743a2a7337b26f0f1220},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42405271. Agents can read the archived copy with the MCP tool read_document.